Search Results - Man, Irit

Refine Results
  1. 1
  2. 2
  3. 3

    Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomise... by Ueno, Makoto, Finn, Richard S, Ren, Zhenggang, Yau, Thomas, Klümpen, Heinz-Josef, Chan, Stephen L, Park, Joon Oh, Pelzer, Uwe, Yu, Li, Siegel, Abby B, Edeline, Julien, Akce, Mehmet, Asselah, Jamil, Assenat, Eric, Aubin, Francine, Barajas, Olga, Ben-Aharon, Irit, Beri, Nina, Berres, Marie-Luise, Brandi, Giovanni, Butthongkomvong, Kritiya, Camandaroba, Marcos, Carballido, Marcela, Chan, Stephan Lam, Chen, Jen-Shi, Chen, Xiaoming, Chon, Hong Jae, Cubillo Gracian, Antonio, Davis, Sarah, De Vos, Judith, Falcone, Alfredo, Fernandez, Plinio, Finn, Richard, Franke, Fabio, Furukawa, Masayuki, Furuse, Junji, Geboes, Karen, Geng, Zhimin, Geva, Ravit, Gou, Hongfeng, Grasselli, Julieta, Hao, Chunyi, Hatoum, Hassan, Heinemann, Volker, Jeyasingam, Vaishnavi, Jimenez Fonseca, Paula, Kasper-Virchow, Stefan, Kelley, Robin, Kim, Jong Gwang, Kinupe Abrahao, Ana Beatriz, Kochenderfer, Mark, Lee, Choong-kun, Lee, Hyun Woo, Lee, Myung Ah, Lee, Wai Man Sarah, Li, Dongliang, Liang, Houjie, Lim, Chun Sen, Low, John, Mao, Yimin, Masi, Gianluca, McCune, Steven, McWhirter, Elaine, Mendez, Guillermo, Mizutani, Tomonori, Moniz, Camila, Morales, Luisa, Munoz Martin, Andres Jesús, Oh, Sang Cheul, Painemal, Claudio, Peng, Chuang, Pezet, Denis, Roohullah, Aflah, Ryu, Hyewon, Schulze, Kornelius, Scott-Brown, Martin, Seufferlein, Thomas, Smolenschi, Cristina, Sookprasert, Aumkhae, Soparattanapaisarn, Nopadol, Starling, Naureen, Stein, Stacey, Sugimoto, Rie, Suksombooncharoen, Thatthan, Tam, Vincent, Tan, Ai Lian, Tanasanvimon, Suebpong, Tonini, Giuseppe, Tsuji, Akihito, Verslype, Chris, Victorino, Ana Paula, Wade, James, Waldschmidt, Dirk Thomas, Wang, Lu, Wan Isahk, Wan Zamaniah, Weschenfelder, Rui, Wong, Chun Yin, Yang, Xuezhong, Yau, Thomas, Zhao, Haitao

    Get full text
    Article
  4. 4
  5. 5

    Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial by Oh, Do-Youn, Yañez, Patricio, Bai, Yuxian, Ryu, Min-Hee, Rivera, Fernando, Alves, Gustavo Vasconcelos, Garrido, Marcelo, Shiu, Kai-Keen, Çil, Timuçin, Pan, Hongming, Wainberg, Zev A, O'Connor, Juan Manuel, Cundom, Juan, Ng, Weng, Peressoni, Mauricio, Andrade, Carlos, Alves, Gustavo, Vianna, Karina, Monteiro, Maria Marcela, Tan, Ann, Asselah, Jamil, Mahave, Mauricio, Salman, Pamela, Liu, Tianshu, Lin, Xiaoyan, Li, Wei, Qu, Yanli, Chen, Ping, Liang, Xinjun, Zhao, Qun, Yin, Xianli, Li, Junhe, Guerrero, Alvaro, Rubiano, Juan, Gonzalez Herrera, Ileana, Melichar, Bohuslav, Buchler, Tomas, Svoboda, Tomas, Vrana, David, Cvek, Jakub, Pfeiffer, Per, Baeksgaard, Lene, Yilmaz, Mette, Boige, Valerie, Lopez-Trabada, Daniel, Hiret, Sandrine, Arnold, Dirk, Martens, Uwe, Castro, Hugo, Lopez, Karla, Chivalan, Marco, Chan, Wendy, Horvath, Zsolt, Lowery, Maeve, Pelles Avraham, Sharon, Di Bartolomeo, Maria, Lonardi, Sara, Yasui, Hisateru, Shoji, Hirokazu, Shibata, Nobuhiro, Yamaguchi, Kensei, Esaki, Taito, Yabusaki, Hiroshi, Tsuji, Akihito, Kadowaki, Shigenori, Martinez Rodriguez, Jorge, Herrera Martinez, Marytere, Balancan, Paola, Castro Oliden, Victor, Grados, Julio, Hajac, Lukasz, Rha, Sun Young, Ryu, Min-Hee, Oh, Do-Youn, Orlova, Rashida, Tjulandin, Sergey, Chan, Sze, Landers, Gregory, Robertson, Barbara, Ruff, Paul, Rivera Herrero, Fernando, Miranda Poma, Jesus, Layos Romero, Laura, Dosso, Sara De, Yen, Chia-Jui, Chen, Yen-Yang, Oksuzoglu, Berna, Hacibekiroglu, Ilhan, Kolesnik, Oleksii, Kryzhanivska, Anna, Leshchenko, Lurii, Ilin, Ievgen, Voitko, Nataliia, Roy, Rajarshi, Shiu, Kai-Keen, Overton, Lindsay, Dunne, Richard, Dayyani, Farshid, Larson, Timothy, Kochenderfer, Mark

    Published in The lancet oncology
    Get full text
    Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20